Navigation Links
Complex Apnea May Explain Sleepless Nights

nosed with central sleep apnea.

Data on medical history, hypertension, diabetes, body mass index, polysomnography, and treatment were reviewed. They excluded all patients with a clinical history of congestive heart failure or a left ventricular ejection fraction at 40% or less, leaving at total of 219 patients for analysis.

The researchers proposed that patients have obstructive apnea if they had five or more combined episodes of obstructive apnea and hypoapneas per hour, or if the patients complained of sleepiness and had 10 or more respiratory-related arousals per hour, which is consistent with the presence of the upper airway resistance syndrome. Patients who have the central apnea index was higher than five events per hour, and at least 50% of the total apnea-hypoapnea index was central in origin and without obstructive components was said to have central sleep apnea. Failure of continuous positive airway pressure to resolve apparent obstructive sleep apnea, complex sleep apnea syndrome may result according to researchers Timothy Morgenthaler, M.D., of the Mayo Clinic, and colleagues, reported in the Sept. 1 issue of Sleep reports that complex sleep apnea syndrome may cause a patient to lose sleep from a combination of physical and neurologic causes.

According to the researchers t poor sleepers with symptoms consistent with both the obstructive and central forms of sleep apnea constitute a poorly recognized class of patients requiring novel therapies.

A consensus panel of sleep experts from the Europe, United States, Asia and Australia recently recommended classification of sleep-related breathing disorders into three clinical entities which are obstructive sleep apnea or hypoapnea syndrome marked by physical causes of airway disruption, central apnea-hypoapnea syndrome, and the Cheyne-Stokes breathing syndrome are related to abnormalities in central nervous control of respiration. However Mayo investigators have
'"/>




Page: 1 2 3 4

Related medicine news :

1. Protein Complex prevents cancer
2. Human Complexity Can Be Attributed To Regulatory Sequence
3. Mystery behind Complex Regional Pain Syndrome Unraveled
4. Scientists Explain Complex Darwinian Evolution
5. Complex Surgery Performed on Eight-Month-Old Egyptian Girl
6. Picture Book Reading Helps Toddlers Grasp Complex Actions
7. Scientists Uncover Complex Workings of Sperm
8. A More Convenient HIV Treatment Is as Effective as More Complex Regimens
9. Structure of Iron Regulatory Protein-RNA Complex Solved
10. Haryana Tourism Complexes to Serve Low Calorie Dishes
11. Sleep Apnea Linked to Bed-Wetting in Kids
Post Your Comments:
(Date:10/8/2008)... HIV-test-kit.com is a new site aimed a....V. from the comfort and privacy of their own home... issue. It is hoped that through home tests more p...he AIDS virus. , New York...eople are getting more used to getting instant res...
(Date:10/8/2008)... Drug Information Association (DIA) wil...-7; Ottawa, Ontario, Canada) to discuss a number o...aceutical industry, health academia, and the healt... PA (PRWEB) October 8, 2008 -- The http://www.diah... host the http://www.diahome.org/diahome/FlagshipM...
(Date:10/8/2008)... AccurateAnswers™ support program...es for http://www.appointment-plus.com [online s... Scottsdale, AZ (PRWEB) October 8, 2008 -- ... scheduling software, continues to expand its soft...n most "software as a service" providers...
(Date:10/8/2008)... Juva Skin & Laser Center is well e...kin treatments in New York City. The facility is l...e, one of the latest skin resurfacing treatments t...e laser equipment. , New ...urgery and laser treatment industry is in the mids...
Breaking Medicine News(10 mins):Health News:HIV Test Kit Markets a New Development in the War Against the AIDS Virus, an Easy Home HIV Testing Device 2Health News:DIA 6th Canadian Annual Meeting Benefit and Risk Management: An Evolution in Progress 2Health News:Appointment-Plus Continues Innovation With Technical Support Program 2Health News:Upscale New York City Skin Care Center Juva Offering FDA Approved Fraxel re:fine System 2
...n therapy with the new biologic drug adalimumab an...es more effective for people with long-standing rh...gement // with methotrexate alone. It has been fou...ents who fail to respond to standard treatment. A...
... Duke Univ. has shown that the surgical outcome of...n non-diabetics. The results were published Aug. 1...// In the largest analysis of its kind, Duke Univ... found that patients with diabetes who require sur...
...s had said that short-acting Beta-agonist (SABA) p...or asthma morbidity of steroid and non-steroid use...Illinois Medicaid, with a diagnosis of asthma from...esearchers from Chicago, IL, obtained the claims f...
...cer does not discriminate between rich and poor, i...ebrities have succumbed to it and some have fought...mous// actresses and personalities who have suffer...ton-John -Actress and SingerShirley Temple Black -...
Other Medicine News:Health News:Ankle Fracture Surgery – Diabetics fare worse than non-diabetics 2Health News:Ankle Fracture Surgery – Diabetics fare worse than non-diabetics 3
(Date:10/7/2008)...lts of FLEXX Trial Presented at the Osteoarthritis...ess, PARSIPPANY, N.J., Oct. 7 /- Fer...ts from the FLEXX Trial of Osteoarthritis of the,K...te), a highly pure,non-avian high molecular weight...is superior to intra-articular saline (IA-saline) ...
(Date:10/7/2008)... COLLINS, Colo., Oct. 7 /- A study pu... embryonic stem cell self-renewal,reported that I...ecombinant,human serum albumin) was an effective r...ure., The article entitled, "The ground state of ...researchers used Cellastim as a recombinant,albumi...
(Date:10/7/2008)...ent, Prospective Randomized Placebo-Controlled Pha...nt Improved Overall Survival., MOUNTAIN VIEW, Cal...eutics has now evaluated the mature Phase II data ...date PROSTVAC(TM) that had been,obtained as part o...al,Cancer Institute (NCI) in the US., The results...
(Date:10/6/2008)...O and CHIPPENHAM, England, October 7 /PRNewswire-F... Mothers Index: 4565) and Vectura,Group plc ("Vect...studies,evaluating the efficacy, safety and tolera...of the European Respiratory Society (ERS) in Berli...rronium bromide), a novel,inhaled long-acting musc...
Breaking Medicine Technology:Study Shows EUFLEXXA(R) Patients Report Significant Improvements in Osteoarthritis of the Knee Pain over a Six Month Period 2Study Shows EUFLEXXA(R) Patients Report Significant Improvements in Osteoarthritis of the Knee Pain over a Six Month Period 3Study Shows EUFLEXXA(R) Patients Report Significant Improvements in Osteoarthritis of the Knee Pain over a Six Month Period 4BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 2BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 3BN ImmunoTherapeutics Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine 4NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 2NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 3NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 4NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 5North Americas northernmost lake affected by global warming 571 1North Americas northernmost lake affected by global warming 571 2TIGroup Names Dennis M Smith as Chief Financial Officer 2083 1TIGroup Names Dennis M Smith as Chief Financial Officer 2083 2TIGroup Names Dennis M Smith as Chief Financial Officer 2083 3TIGroup Names Dennis M Smith as Chief Financial Officer 2083 4Agendia Joins the Personalized Medicine Coalition 28PMC 29 852 1Agendia Joins the Personalized Medicine Coalition 28PMC 29 852 2Beaumont Technology Usability Center To Offer Training For Medical Technology Companies 847 1Beaumont Technology Usability Center To Offer Training For Medical Technology Companies 847 2
...lood Glucose,Control and Progressive Weight Loss -... Amylin,Pharmaceuticals, Inc. and Eli Lilly and Co...owed BYETTA(R) (exenatide) injection,sustained imp...ight,loss through three and a half years of therap...vements in cardiovascular risk,factors in people w...
...2007--Gilead,Sciences, Inc. (Nasdaq:GILD) today an... evaluating the company,s once-daily,anti-HIV drug...ovir,DF) 300 mg as a potential treatment for chron...ary efficacy endpoint. The data show,that Viread i...al,drug Hepsera(R) (adefovir dipivoxil) among pati...
Other Medicine Technology:Byetta Treatment for Three and a Half Years Associated with,Reductions in Cardiovascular Risk Factors in People with Type 2,Diabetes 2Byetta Treatment for Three and a Half Years Associated with,Reductions in Cardiovascular Risk Factors in People with Type 2,Diabetes 3Byetta Treatment for Three and a Half Years Associated with,Reductions in Cardiovascular Risk Factors in People with Type 2,Diabetes 4Byetta Treatment for Three and a Half Years Associated with,Reductions in Cardiovascular Risk Factors in People with Type 2,Diabetes 5Byetta Treatment for Three and a Half Years Associated with,Reductions in Cardiovascular Risk Factors in People with Type 2,Diabetes 6Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint 2Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint 3Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint 4Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint 5Second Phase III Study Evaluating Gilead's Viread for the Treatment,of Chronic Hepatitis B Virus Meets Primary Endpoint 6
...ydroepiandrosterone sulfate (DHEA-S) is the sulfat...and by enzymatic conversion of DHEA in adrenal and...d secreted by the adrenal cortex, and is a precurs...A possesses relatively weak androgenic activity, w...
EL-RF-IgM is high sensitivity quantitative rheumatoid factor IgM.
The Diamedix immunosimplicity® Is- Rheumatoid Factor Test Kit is an EIA procedure intended for the quantitation of IgM antibodies to IgG antigen. The results are reported in IU/mL, traceable to t
The SYNCHRON CX4 Delta Specialty / Drug Clinical System is a random access analyzer that can consolidate Drugs of Abuse, TDM's and other specialty testing, such as thyroid, HbA1c and lipids in one co
Medicine Products: